Pandite Arundathy N. 4
4 · Shattuck Labs, Inc. · Filed Jan 12, 2022
Insider Transaction Report
Form 4
Pandite Arundathy N.
Chief Medical Officer
Transactions
- Award
Common Stock
2022-01-10+34,738→ 140,904 total - Award
Stock Option (Right to Buy)
2022-01-10+69,475→ 69,475 totalExercise: $7.43Exp: 2032-01-10→ Common Stock (69,475 underlying)
Footnotes (2)
- [F1]Consists of 34,738 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2023, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represented a right to purchase a total of 69,475 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2023, with the remaining three quarters vesting in equal monthly installments through January 10, 2026, subject to the Reporting Person's continued service to the Issuer.